サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1528015

神経刺激装置の世界市場

Neurostimulation Devices

出版日
ページ情報
英文 163 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
神経刺激装置の世界市場
出版日: 2024年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 163 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経刺激装置の世界市場は2030年までに132億米ドルに達する見込み

2023年に80億米ドルと推定される神経刺激装置の世界市場は、2023年から2030年にかけてCAGR 7.3%で成長し、2030年には132億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである脊髄刺激装置は、CAGR 8.3%を記録し、分析期間終了時には48億米ドルに達すると予測されます。深部脳刺激装置セグメントの成長率は、分析期間中CAGR 7.5%と推定されます。

米国市場は22億米ドル、中国はCAGR 11.9％で成長すると予測

米国の神経刺激装置市場は2023年に22億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに31億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは11.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と7.6%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の神経刺激装置市場- 主要動向と促進要因まとめ

神経刺激装置とは何か、なぜ重要なのか？

神経刺激装置は、電気刺激によって神経系の活動を変化させるように設計された高度な医療技術です。これらのデバイスは、様々な神経疾患や慢性疼痛症状の治療に使用され、従来の治療がうまくいかなかった場合に治療の選択肢を提供します。一般的な用途としては、慢性疼痛管理に対する脊髄刺激、パーキンソン病などの運動障害に対する脳深部刺激、てんかんやうつ病に対する迷走神経刺激などがあります。神経刺激装置の意義は、最小限の侵襲性で標的療法を提供し、患者に衰弱症状の緩和と生活の質の向上をもたらす能力にあります。これらの装置の精度と有効性により、複雑な神経疾患を管理するためのツールキットの重要な構成要素となっています。

技術の進歩はどのように神経刺激装置を向上させているのか？

技術の進歩は神経刺激装置の機能と応用を絶えず向上させています。主な技術革新のひとつは、クローズドループシステムの開発で、患者の生理学的反応に基づいて刺激パラメーターをリアルタイムで自動的に調整することができます。これにより、副作用を最小限に抑えながら、最適な治療結果を得ることができます。また、バッテリー技術の進歩により、より長寿命で効率的な装置が開発され、バッテリー交換のための外科手術の頻度が減少しています。さらに、ワイヤレス技術の統合により、遠隔モニタリングや調整が可能になり、患者とヘルスケア提供者の双方にとって利便性が向上しています。マイクロエレクトロニクスと生体適合材料の調査により、侵襲が少なく、患者にとってより快適な、より小型で目立たないインプラントが開発されています。このような技術的進歩は、神経刺激装置の機能性や使い勝手を向上させるだけでなく、より幅広い症状の治療への応用の可能性を広げています。

神経刺激市場における新たな動向とイノベーションとは？

神経刺激市場は、その将来を形作ることになるいくつかの新たな動向と技術革新を目の当たりにしています。重要な傾向の1つは、個別化医療への注目の高まりであり、神経刺激療法は患者固有の神経学的プロファイルに基づいて個々の患者の特定のニーズに合わせて調整されます。もう1つの重要な進展は、うつ病や不安障害などの精神疾患、さらにはアルツハイマー病などの神経変性疾患における認知機能強化など、従来とは異なる分野での神経刺激の応用が拡大していることです。また、経頭蓋磁気刺激（TMS）や経皮的電気神経刺激（TENS）など、外科的植え込みを必要とせずに治療効果をもたらす非侵襲的な神経刺激装置に対する関心も急増しています。さらに、人工知能（AI）や機械学習アルゴリズムを用いた神経刺激装置の研究が進むことで、治療プロトコルがさらに洗練・強化され、より効果的で個別化された治療オプションが提供されることが期待されます。こうした動向は、神経刺激市場のダイナミックで革新的な性質を浮き彫りにしており、患者の転帰を改善し治療の可能性を拡大するための絶え間ない探求がその原動力となっています。

神経刺激装置市場の成長を促す要因は何か？

神経刺激装置市場の成長は、いくつかの要因によってもたらされます。まず、慢性疼痛や神経障害の有病率の増加が重要な原動力となっています。これらの疾患では、神経刺激装置が提供できる長期管理が必要となることが多いからです。クローズドループシステムやワイヤレス機能の開発などの技術的進歩は、機器の機能性や患者のコンプライアンスを向上させることで市場の成長を促進しています。精神疾患や認知障害の治療における神経刺激の応用拡大が、新たな市場機会をもたらしています。さらに、個々の患者のニーズに合わせて治療を行う個別化医療へのシフトが、高度な神経刺激ソリューションの需要を促進しています。規制当局の承認や有利な償還政策も、こうした高度な治療法をより利用しやすくすることで市場の拡大を促進しています。さらに、神経疾患や慢性疼痛に罹患しやすい世界人口の高齢化が、神経刺激装置の採用拡大に寄与しています。最後に、医療従事者と患者の双方において、神経刺激療法が現実的な治療選択肢であるという認識と受容が高まっていることが市場成長の原動力となっており、複雑な病状の管理において神経刺激装置がますます重要な役割を果たすようになっています。

調査対象企業の例（注目の32社）

  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-1227

Global Neurostimulation Devices Market to Reach US$13.2 Billion by 2030

The global market for Neurostimulation Devices estimated at US$8.0 Billion in the year 2023, is expected to reach US$13.2 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Spinal Cord Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$4.8 Billion by the end of the analysis period. Growth in the Deep Brain Stimulation Devices segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Neurostimulation Devices market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Neurostimulation Devices Market - Key Trends and Drivers Summarized

What Are Neurostimulation Devices and Why Are They Important?

Neurostimulation devices are sophisticated medical technologies designed to alter nervous system activity through electrical stimulation. These devices are used to treat a variety of neurological disorders and chronic pain conditions, offering a therapeutic option where traditional treatments may have failed. Common applications include spinal cord stimulation for chronic pain management, deep brain stimulation for movement disorders like Parkinson’s disease, and vagus nerve stimulation for epilepsy and depression. The significance of neurostimulation devices lies in their ability to provide targeted therapy with minimal invasiveness, offering patients relief from debilitating symptoms and improving their quality of life. The precision and effectiveness of these devices have made them a crucial component in the toolkit for managing complex neurological conditions.

How Are Technological Advancements Enhancing Neurostimulation Devices?

Technological advancements are continuously enhancing the capabilities and applications of neurostimulation devices. One of the major innovations is the development of closed-loop systems, which can automatically adjust stimulation parameters in real-time based on the patient's physiological responses. This ensures optimal therapeutic outcomes while minimizing side effects. Advances in battery technology have also led to longer-lasting and more efficient devices, reducing the frequency of surgical interventions for battery replacements. Furthermore, the integration of wireless technology allows for remote monitoring and adjustments, providing greater convenience for both patients and healthcare providers. Research into microelectronics and biocompatible materials has resulted in smaller, more discreet implants that are less invasive and more comfortable for patients. These technological strides not only improve the functionality and usability of neurostimulation devices but also expand their potential applications in treating a broader range of conditions.

What Are the Emerging Trends and Innovations in the Neurostimulation Market?

The neurostimulation market is witnessing several emerging trends and innovations that are set to shape its future. One significant trend is the increasing focus on personalized medicine, where neurostimulation therapies are tailored to the specific needs of individual patients based on their unique neurological profiles. Another important development is the growing application of neurostimulation in non-traditional areas such as psychiatric disorders, including depression and anxiety, and even for cognitive enhancement in neurodegenerative diseases like Alzheimer's. The market is also seeing a surge in interest for non-invasive neurostimulation devices, such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS), which offer therapeutic benefits without the need for surgical implantation. Additionally, ongoing research into the use of artificial intelligence (AI) and machine learning algorithms in neurostimulation devices promises to further refine and enhance treatment protocols, providing more effective and individualized therapy options. These trends highlight the dynamic and innovative nature of the neurostimulation market, driven by the constant quest to improve patient outcomes and expand therapeutic possibilities.

What Factors Are Driving the Growth in the Neurostimulation Devices Market?

The growth in the neurostimulation devices market is driven by several factors. Firstly, the increasing prevalence of chronic pain and neurological disorders is a significant driver, as these conditions often require long-term management that neurostimulation devices can provide. Technological advancements, such as the development of closed-loop systems and wireless capabilities, are propelling market growth by enhancing device functionality and patient compliance. The expanding applications of neurostimulation in treating psychiatric disorders and cognitive impairments are opening new market opportunities. Additionally, the shift towards personalized medicine, where treatments are tailored to individual patient needs, is driving demand for sophisticated neurostimulation solutions. Regulatory approvals and favorable reimbursement policies are also facilitating market expansion by making these advanced therapies more accessible. Furthermore, the aging global population, which is more susceptible to neurological and chronic pain conditions, is contributing to the increased adoption of neurostimulation devices. Finally, growing awareness and acceptance of neurostimulation as a viable therapeutic option among both healthcare providers and patients are fueling market growth, ensuring these devices play an increasingly vital role in managing complex medical conditions.

Select Competitors (Total 32 Featured) -

  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Neurostimulation Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Neurological Disorders Spurs Growth in Neurostimulation Devices
    • Technological Advancements in Closed-Loop Systems Propel Market Expansion
    • Personalized Medicine Expands Addressable Market Opportunity for Tailored Neurostimulation Therapies
    • Non-Invasive Neurostimulation Devices Here's How They Drive Adoption
    • Integration of Wireless Technology Strengthens Business Case for Remote Monitoring and Adjustments
    • Growing Applications in Psychiatric Disorders Generates Demand for Advanced Neurostimulation Solutions
    • Aging Global Population Throws the Spotlight on Increased Neurostimulation Device Adoption
    • Artificial Intelligence and Machine Learning Accelerates Demand for Intelligent Neurostimulation Devices
    • Increasing Use in Cognitive Enhancement for Neurodegenerative Diseases Expands Market Reach
    • Rising Awareness and Acceptance Drives Adoption Among Healthcare Providers and Patients
    • Advances in Microelectronics and Biocompatible Materials Sustain Growth in Device Miniaturization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurostimulation Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurostimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Spinal Cord Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Spinal Cord Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Deep Brain Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sacral Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Sacral Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vagus Nerve Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Vagus Nerve Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Gastric Electric Stimulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Gastric Electric Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Parkinson's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Parkinson's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Parkinson's by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Alzheimer's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Alzheimer's by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Alzheimer's by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurostimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurostimulation Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: India 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: India 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurostimulation Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurostimulation Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Neurostimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Neurostimulation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Neurostimulation Devices by Product - Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Neurostimulation Devices by Product - Percentage Breakdown of Value Sales for Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices and Other Products for the Years 2014, 2024 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neurostimulation Devices by Application - Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Neurostimulation Devices by Application - Percentage Breakdown of Value Sales for Pain Management, Epilepsy, Parkinson's, Urinary & Fecal Incontinence, Alzheimer's and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION